Will USPTO’s PTAB Undergo A Makeover? Senators Push Reform Bill, Patent Office Tweaks Policy
Executive Summary
Parallel district court litigation would no longer be factor in deciding whether to institute PTAB review of patents under Senate bill. BIO favors PTO discretion, would like claim amendments to be addressed.
You may also be interested in...
Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress
Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. Industry groups criticize the proposals.
Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress
Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. PhRMA, BIO, AAM criticize the proposals.
Patent Protection: Should Third Parties Be Able To Request PTO Director Review Of PTAB Decisions?
Agency asks stakeholders to weigh in on the process for director review of decisions by the Patent Trial and Appeal Board. PTO questions whether review should be limited to final written decisions and if the precedential opinion process should remain in effect.